Deliver to United Kingdom
0

HPLC column NUCLEODUR ® π 2 , 3 µm, 100 mm, 2 mm

£ 778.86*

*Prices plus VAT plus shipping costs

£ 934.63*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® π 2 , 3 µm, 100 mm, 2 mm

Order number: 34T3.1

Part number: AC100008252

Out of Stock

Price Breakdown

1

6

24

Suitable for laboratory and industrial environments, the HPLC column NUCLEODUR ® Π 2 offers an alternative selectivity compared to traditional C 18 modifications due to its biphenylpropyl modification and unique π-π and hydrophobic interactions. This reversed-phase column is ideal for separating aromatic and unsaturated substances, particularly antibiotics, pharmaceutical products, steroids, and other polar compounds. With a particle size of 3 μm, pore size of 110 Å, and pressure stability up to 600 bar, this fully porous particle (FPP) column ensures reliable performance even under challenging conditions. Its temperature stability of 60°C and compatibility with acetonitrile-water eluents make it versatile for various applications. The HPLC column NUCLEODUR ® Π 2 comes with

  • Category: Separation columns for HPLC
  • L x Ø internal (column): 100 x 2 mm
  • Separation principle: Reversed phase (RP)
  • Application Database (Macherey-Nagel): HPLC
  • Pressure stability: 600 bar
  • Endcapped: yes
  • Pore volume: 0.9 ml/g
  • Column shape: Analytical separation column
  • Temperature stability: 60 ° C
  • Pore size: 110 Å
  • Phase: π 2
  • Column type: HPLC column
  • Particle size: 3 µm
  • Specific surface according to BET: 340 m²/g
  • Surface chemistry: Biphenylpropyl modification
  • USP listing: L11
  • pH stability: 3,0-10,0
  • Particle type: Fully porous particles (FPP)
  • Eluent in column: Acetonitrile - Water
  • Recommended application(s): Antibiotics Particularly aromatic and unsaturated compounds Pharmaceutical products Especially for polar compounds Steroids
  • Interactions / retention mechanism: π-π and hydrophobic
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.